FI881388A0 - Molekylaera maerkaemnen. - Google Patents

Molekylaera maerkaemnen.

Info

Publication number
FI881388A0
FI881388A0 FI881388A FI881388A FI881388A0 FI 881388 A0 FI881388 A0 FI 881388A0 FI 881388 A FI881388 A FI 881388A FI 881388 A FI881388 A FI 881388A FI 881388 A0 FI881388 A0 FI 881388A0
Authority
FI
Finland
Prior art keywords
molekylaera
maerkaemnen
molekylaera maerkaemnen
Prior art date
Application number
FI881388A
Other languages
English (en)
Other versions
FI881388A (fi
Inventor
Paul Elvin
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of FI881388A0 publication Critical patent/FI881388A0/fi
Publication of FI881388A publication Critical patent/FI881388A/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5748—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
FI881388A 1987-03-23 1988-03-23 Molekylaera maerkaemnen. FI881388A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2945687A 1987-03-23 1987-03-23

Publications (2)

Publication Number Publication Date
FI881388A0 true FI881388A0 (fi) 1988-03-23
FI881388A FI881388A (fi) 1988-09-24

Family

ID=21849102

Family Applications (1)

Application Number Title Priority Date Filing Date
FI881388A FI881388A (fi) 1987-03-23 1988-03-23 Molekylaera maerkaemnen.

Country Status (10)

Country Link
EP (1) EP0284362A3 (fi)
JP (1) JPS6434291A (fi)
AU (1) AU625169B2 (fi)
DK (1) DK159788A (fi)
FI (1) FI881388A (fi)
IL (1) IL85838A0 (fi)
NO (1) NO881273L (fi)
NZ (1) NZ223985A (fi)
PT (1) PT87055B (fi)
ZA (1) ZA882082B (fi)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89964A0 (en) * 1988-04-15 1989-12-15 Montefiore Med Center Method for determining malignant progression,cdna,polypeptides encoded thereby and pharmaceutical compositions containing the same
US5330892A (en) * 1991-03-13 1994-07-19 The Johns Hopkins University MCC gene (mutated in colorectal cancer) used for diagnosis of cancer in humans
US6025127A (en) * 1994-01-14 2000-02-15 The Johns Hopkins University School Of Medicine Nucleic acid mutation detection in histologic tissue
US5677125A (en) * 1994-01-14 1997-10-14 Vanderbilt University Method of detection and diagnosis of pre-invasive cancer
US5670325A (en) * 1996-08-14 1997-09-23 Exact Laboratories, Inc. Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
US5741650A (en) * 1996-01-30 1998-04-21 Exact Laboratories, Inc. Methods for detecting colon cancer from stool samples
US6203993B1 (en) 1996-08-14 2001-03-20 Exact Science Corp. Methods for the detection of nucleic acids
US6100029A (en) * 1996-08-14 2000-08-08 Exact Laboratories, Inc. Methods for the detection of chromosomal aberrations
US6300077B1 (en) 1996-08-14 2001-10-09 Exact Sciences Corporation Methods for the detection of nucleic acids
US6146828A (en) * 1996-08-14 2000-11-14 Exact Laboratories, Inc. Methods for detecting differences in RNA expression levels and uses therefor
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US5952178A (en) * 1996-08-14 1999-09-14 Exact Laboratories Methods for disease diagnosis from stool samples
US6020137A (en) * 1996-08-14 2000-02-01 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6333152B1 (en) 1997-05-21 2001-12-25 The Johnshopkins University Gene expression profiles in normal and cancer cells
US6406857B1 (en) 1997-06-16 2002-06-18 Exact Sciences Corporation Methods for stool sample preparation
US6268136B1 (en) 1997-06-16 2001-07-31 Exact Science Corporation Methods for stool sample preparation
WO1999050289A2 (en) * 1998-03-31 1999-10-07 Nan Zhang Transformation progression-related genes and their use
US6262333B1 (en) 1998-06-10 2001-07-17 Bayer Corporation Human genes and gene expression products
EP1593687A3 (en) * 1998-06-10 2006-10-18 Bayer Corporation Human genes differentially expressed in colon cancer
US7258973B2 (en) 1998-08-31 2007-08-21 Mayo Foundation For Medical Education & Research Method for detecting a differentially expressed sequence
JP2002523088A (ja) * 1998-08-31 2002-07-30 バイエル コーポレイション 結腸癌において示差的に発現されるヒト遺伝子
US6503718B2 (en) 1999-01-10 2003-01-07 Exact Sciences Corporation Methods for detecting mutations using primer extension for detecting disease
US6280947B1 (en) 1999-08-11 2001-08-28 Exact Sciences Corporation Methods for detecting nucleotide insertion or deletion using primer extension
DE60028732T2 (de) 1999-02-25 2007-06-14 Exact Sciences Corp., Maynard Verfahren zur erhaltung der dns-integrität
US6586177B1 (en) 1999-09-08 2003-07-01 Exact Sciences Corporation Methods for disease detection
EP1238113B1 (en) 1999-12-07 2010-02-24 EXACT Sciences Corporation Detection of lung neoplasms in stool
US20040265804A1 (en) * 2000-07-25 2004-12-30 Oliver Von Stein Method for identifying metastatic tumor cells
KR100788092B1 (ko) 2001-06-20 2007-12-21 제넨테크, 인크. 종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
US20050272120A1 (en) 2001-06-20 2005-12-08 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US7803915B2 (en) 2001-06-20 2010-09-28 Genentech, Inc. Antibody compositions for the diagnosis and treatment of tumor
AU2003213107A1 (en) 2002-02-15 2003-09-09 Exact Sciences Corporation Methods for analysis of molecular events
WO2004001072A2 (en) * 2002-06-19 2003-12-31 Oncotherapy Science, Inc. Method for diagnosis of colorectal tumors
US20080199468A1 (en) * 2004-02-24 2008-08-21 Oncotherapy Science, Inc. Method For Diagnosing Colorectal Cancers
US7981607B2 (en) 2004-08-27 2011-07-19 Esoterix Genetic Laboratories LLC Method for detecting recombinant event
WO2006047787A2 (en) 2004-10-27 2006-05-04 Exact Sciences Corporation Method for monitoring disease progression or recurrence
CN1300580C (zh) * 2004-12-31 2007-02-14 中国人民解放军第306医院 检测肝癌血清特征蛋白的质谱模型及其制备方法和应用
WO2007044071A2 (en) 2005-04-21 2007-04-19 Exact Sciences Corporation Analysis of heterogeneous nucleic acid samples
DE602006017664D1 (de) * 2006-06-02 2010-12-02 Fraunhofer Ges Forschung Verfahren zu der Identifizierung von genetischen Markern für Sekundärtumore und Mittel zur Identifizierung, Markierung und zur gezielten Behandlung von sekundären Tumoren

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61152287A (ja) * 1984-12-27 1986-07-10 Sankyo Co Ltd 癌特異的ｃＤＮＡ
JPH02500323A (ja) * 1986-08-13 1990-02-08 ザ、ゼネラル、ホスピタル、コーポレーション 結腸病変用検出マーカー

Also Published As

Publication number Publication date
NO881273L (no) 1988-09-26
EP0284362A3 (en) 1990-04-04
PT87055A (pt) 1988-04-01
AU1337888A (en) 1988-09-22
NZ223985A (en) 1991-05-28
FI881388A (fi) 1988-09-24
JPS6434291A (en) 1989-02-03
EP0284362A2 (en) 1988-09-28
DK159788A (da) 1988-09-24
IL85838A0 (en) 1988-09-30
ZA882082B (en) 1988-12-28
DK159788D0 (da) 1988-03-23
PT87055B (pt) 1992-07-31
NO881273D0 (no) 1988-03-23
AU625169B2 (en) 1992-07-02

Similar Documents

Publication Publication Date Title
DE3880632D1 (de) Kuevette.
DE3881291D1 (de) Sehapparat.
DE3862564D1 (de) Erdanker.
FI881388A0 (fi) Molekylaera maerkaemnen.
FI77952B (fi) Ljusbaogsrelae.
DE3883705D1 (de) Alkenylbicyclohexane.
DE3785663D1 (de) Loetgeraet.
NO884725L (no) Raffinoersegment.
DE3876304D1 (de) Polysilacylobutasilazane.
DE3882446D1 (de) Polydisilacyclobutasilazane.
DE3870513D1 (de) Tennisball.
FI883766A (fi) Acylderivat.
DE3888991D1 (de) Aminokohlenwasserstoff-substituierte Ketoximosilane.
FI77055B (fi) Vaermegradient-inkubator.
DE3879348D1 (de) Fm-cw-radargeraet.
DE3862309D1 (de) Aminomethyltetrahydrofurane.
DE3878970T2 (de) Praeparative chromatographiesaeule.
DE3853279T2 (de) Laryngoskop.
ES2023228B3 (es) Ciclopropancarboxamidas.
DE3860710D1 (de) Exklusiv-oder-schaltung.
DE3860307D1 (de) 2-aminomethyltetrahydrofurane.
FI871156A (fi) Haollare foer en blankett.
DE3866770D1 (de) Gerbstoff.
FI882566A (fi) Inspektionsstation foer en kontinuerligt producerad materialbana.
DE3879625T2 (de) Laseroszillator.

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: IMPERIAL CHEMICAL INDUSTRIES PLC